FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015018344> ?p ?o ?g. }

• W3015018344 endingPage "106" @default.
• W3015018344 startingPage "102" @default.
• W3015018344 abstract "Hepatorenal syndrome (HRS) remains a serious complication of cirrhosis with a high mortality rate. There is little information on the effect of standardizing albumin, midodrine and octreotide combination on treatment response in patients with HRS.The aim of the study was to determine the impact of a standardized HRS treatment regimen on renal function recovery. The primary outcome was full response rate. Secondary outcomes included partial and no response rates, 30-day all-cause mortality, ICU length of stay (LOS), hospital LOS, liver transplantation and total dose of albumin.This retrospective study evaluated the impact of using a standardized approach with albumin, midodrine and octreotide on treatment response rates compared to a historical group.Of the patients with HRS, 28 received a standardized approach with albumin, midodrine and octreotide while 60 received a nonstandardized approach. Ten percent of patients achieved full response in the prestandardization group compared with 25% in the poststandardization group (P = 0.07). Renal replacement therapy was significantly more prevalent in the prestandardization group vs. poststandardization group (45% vs. 21.4%, P = 0.03). Liver transplantation was performed significantly more often in the prestandardization group compared the poststandardization group (23% vs. 3.6%, P = 0.02). Amount of albumin used was statistically lower in the poststandardization group (425 vs. 332 g, P = 0.05). No significant differences in days of HRS treatment, mortality rate, hospital and ICU LOS were observed.A trend towards improved treatment response rate was observed after standardizing the HRS treatment regimen. Standardized therapy led to significantly lower rates of renal replacement therapy and liver transplantation, suggesting patients in poststandardization were effectively managed medically without requiring further intervention." @default.
• W3015018344 created "2020-04-10" @default.
• W3015018344 creator A5012912762 @default.
• W3015018344 creator A5039771006 @default.
• W3015018344 creator A5050132843 @default.
• W3015018344 creator A5051429604 @default.
• W3015018344 creator A5066423578 @default.
• W3015018344 creator A5070437827 @default.
• W3015018344 date "2020-03-20" @default.
• W3015018344 modified "2023-10-15" @default.
• W3015018344 title "Standardized approach of albumin, midodrine and octreotide on hepatorenal syndrome treatment response rate" @default.
• W3015018344 cites W1846601160 @default.
• W3015018344 cites W1899691766 @default.
• W3015018344 cites W1967589221 @default.
• W3015018344 cites W1968272089 @default.
• W3015018344 cites W2011458442 @default.
• W3015018344 cites W2024929331 @default.
• W3015018344 cites W2045620941 @default.
• W3015018344 cites W2049714815 @default.
• W3015018344 cites W2061489021 @default.
• W3015018344 cites W2065073136 @default.
• W3015018344 cites W2074466817 @default.
• W3015018344 cites W2074600297 @default.
• W3015018344 cites W2094598763 @default.
• W3015018344 cites W2098913448 @default.
• W3015018344 cites W2214600008 @default.
• W3015018344 cites W2547147169 @default.
• W3015018344 cites W2594621641 @default.
• W3015018344 cites W2597931048 @default.
• W3015018344 cites W2765533712 @default.
• W3015018344 cites W2890161092 @default.
• W3015018344 doi "https://doi.org/10.1097/meg.0000000000001700" @default.
• W3015018344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32243349" @default.
• W3015018344 hasPublicationYear "2020" @default.
• W3015018344 type Work @default.
• W3015018344 sameAs 3015018344 @default.
• W3015018344 citedByCount "5" @default.
• W3015018344 countsByYear W30150183442020 @default.
• W3015018344 countsByYear W30150183442021 @default.
• W3015018344 countsByYear W30150183442022 @default.
• W3015018344 countsByYear W30150183442023 @default.
• W3015018344 crossrefType "journal-article" @default.
• W3015018344 hasAuthorship W3015018344A5012912762 @default.
• W3015018344 hasAuthorship W3015018344A5039771006 @default.
• W3015018344 hasAuthorship W3015018344A5050132843 @default.
• W3015018344 hasAuthorship W3015018344A5051429604 @default.
• W3015018344 hasAuthorship W3015018344A5066423578 @default.
• W3015018344 hasAuthorship W3015018344A5070437827 @default.
• W3015018344 hasConcept C126322002 @default.
• W3015018344 hasConcept C141071460 @default.
• W3015018344 hasConcept C159641895 @default.
• W3015018344 hasConcept C179755657 @default.
• W3015018344 hasConcept C2776125364 @default.
• W3015018344 hasConcept C2776297358 @default.
• W3015018344 hasConcept C2776988256 @default.
• W3015018344 hasConcept C2777214474 @default.
• W3015018344 hasConcept C2779609443 @default.
• W3015018344 hasConcept C2780081974 @default.
• W3015018344 hasConcept C2781025020 @default.
• W3015018344 hasConcept C2781413609 @default.
• W3015018344 hasConcept C2911091166 @default.
• W3015018344 hasConcept C2992208098 @default.
• W3015018344 hasConcept C71924100 @default.
• W3015018344 hasConcept C73787029 @default.
• W3015018344 hasConcept C84393581 @default.
• W3015018344 hasConcept C90924648 @default.
• W3015018344 hasConceptScore W3015018344C126322002 @default.
• W3015018344 hasConceptScore W3015018344C141071460 @default.
• W3015018344 hasConceptScore W3015018344C159641895 @default.
• W3015018344 hasConceptScore W3015018344C179755657 @default.
• W3015018344 hasConceptScore W3015018344C2776125364 @default.
• W3015018344 hasConceptScore W3015018344C2776297358 @default.
• W3015018344 hasConceptScore W3015018344C2776988256 @default.
• W3015018344 hasConceptScore W3015018344C2777214474 @default.
• W3015018344 hasConceptScore W3015018344C2779609443 @default.
• W3015018344 hasConceptScore W3015018344C2780081974 @default.
• W3015018344 hasConceptScore W3015018344C2781025020 @default.
• W3015018344 hasConceptScore W3015018344C2781413609 @default.
• W3015018344 hasConceptScore W3015018344C2911091166 @default.
• W3015018344 hasConceptScore W3015018344C2992208098 @default.
• W3015018344 hasConceptScore W3015018344C71924100 @default.
• W3015018344 hasConceptScore W3015018344C73787029 @default.
• W3015018344 hasConceptScore W3015018344C84393581 @default.
• W3015018344 hasConceptScore W3015018344C90924648 @default.
• W3015018344 hasIssue "1" @default.
• W3015018344 hasLocation W30150183441 @default.
• W3015018344 hasLocation W30150183442 @default.
• W3015018344 hasOpenAccess W3015018344 @default.
• W3015018344 hasPrimaryLocation W30150183441 @default.
• W3015018344 hasRelatedWork W1664037137 @default.
• W3015018344 hasRelatedWork W2049714815 @default.
• W3015018344 hasRelatedWork W2089280745 @default.
• W3015018344 hasRelatedWork W2110616090 @default.
• W3015018344 hasRelatedWork W2184299787 @default.
• W3015018344 hasRelatedWork W2978803164 @default.
• W3015018344 hasRelatedWork W2981594675 @default.
• W3015018344 hasRelatedWork W3210425024 @default.
• W3015018344 hasRelatedWork W4205141971 @default.

• next